Sponsored By

Exploring the CBD opportunity – report

Brands seek to meet consumer needs, even as regulatory uncertainty challenges broad market expansion.

Heather Granato

December 17, 2020

1 Min Read
VFI CBD feature 1540x800
© iStock

The COVID-19 pandemic has wreaked havoc around the globe, separating families, plunging nations into economic distress and exacerbating underlying health issues. It's no wonder consumers are reporting higher levels of insomnia, stress and anxiety—and accelerated interest in CBD products. Market data supports information about new consumer usage, and consistent interest in CBD for its sleep, relaxation and health management abilities. Covered in this CBD report: 

  • Assessing CBD in Europe and identifying key restrictions hindering market growth 

  • The evolution of delivery formats and addressing bioavailability 

  • Clinical research substantiating health effects and efficacy 

  • Regulatory update on the status of CBD in Europe and what this means for brands

  • Tapping into a restricted market that continues to draw consumer interest 

Underwritten by: 

Swiss Pharmacan Logo

Read more about:

Reports
SUBSCRIBE TO OUR FREE NEWSLETTERS
Get your dose of nutrition science, health ingredient innovations, and nutraceutical R&D!